AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 17 No. 6, June 2007
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millichap, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Millichap, J. G.

AAP Grand Rounds 17:68 (2007)
© 2007 American Academy of Pediatrics

NEUROLOGY

Outcome of Chronic Daily Headache in Adolescents

Source: Wang S-J, Fuh J-L, Lu S-R, et al. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology. 2007;68:591–596; doi:10.1212/01. wnl.0000252800.82704.62[Abstract/Free Full Text]

The first 20% of the full text of this article appears below.

Outcomes and predictors of chronic daily headache (CDH) were determined in a two-year longitudinal study of a sample of 122 adolescents (32 male/90 female; ages 12–14) based on annual telephone follow-up by neurologists at Taipei Veterans General Hospital, Taiwan. CDH was defined as ≥15 headache days/month, average of two hours/day or more, for more than three months. All study patients met criteria for CDH at enrollment in 2000. Follow-up response rates were 92% in 2001 and 84% in 2002. Average monthly headache frequency for study patients was 11.0 ± 9.7 days during the first year of follow-up and 7.7 ± 6.5 days in the subsequent year. At the one-year follow-up, symptoms in 40% of study patients met criteria for CDH; by the year two follow-up the persistence rate was 25%. A gender difference was observed: only 4% of boys . . . [Full Text of this Article]

J. Gordon Millichap, MD, FAAP
Neurology, Children’s Memorial Hospital, Northwestern University Medical School, Chicago, IL.

 






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Academy of Pediatrics.